← Back

AMN Healthcare Services Inc

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Price · split & dividend adjusted
News & notes moving AMN
AMN

AMN Healthcare Stock Rallies 119% on Staffing Demand Rebound

AMN Healthcare Services stock has jumped 118.7% year to date, far outpacing its industry's 10.9% gain and the S&P 500's 11.7% growth. Second-quarter revenues rose 2.3% year over year to $673 million, 6% above the high end of guidance, while adjusted EPS jumped 158% to 77 cents. Travel nurse volume increased 6% and allied volume rose 7% in the second quarter, the strongest growth rates for both businesses in four years, and third-quarter guidance calls for more than 10% volume growth in both segments. The Zacks Consensus Estimate projects 2026 EPS of $3.10, up 127.9% year over year, on revenues of $3.30 billion, up 20.9%. AMN also acquired ESSENTIAL Brand Leadership Assessment and Jaide Health to expand its technology-enabled workforce solutions.
Zacks Investment Research·2dRead more ▾
AMN2

AMN Healthcare Q2 Earnings Beat Driven by Nurse and Allied Demand

AMN Healthcare Services reported second quarter results that exceeded Wall Street expectations, with revenue of $673.2 million versus analyst estimates of $628.2 million and adjusted EPS of $0.77 versus estimates of $0.19. CEO Caroline Grace attributed the strong performance primarily to robust demand in the Nurse and Allied Solutions segment, with travel nurse and allied staffing volumes growing at their highest rate in four years. The company also benefited from higher-than-expected labor disruption revenue and improved execution in its search and international nurse businesses. Revenue guidance for Q3 CY2026 is $647.5 million at the midpoint, above analyst estimates of $618.2 million. During the earnings call, analysts questioned management on contingent labor premiums, margin assumptions, bill rates, acquisitions, and hospital permanent hiring slowdowns.
StockStory·12dRead more ▾
AMN3

AMN Healthcare Q2 revenue beats estimates on nurse and allied demand surge

AMN Healthcare Services reported second-quarter revenue of $673.2 million, beating analyst estimates of $628.2 million and growing 2.3% year on year, driven by robust demand in its Nurse and Allied Solutions segment. Adjusted earnings per share of $0.77 significantly exceeded the consensus estimate of $0.19, while adjusted EBITDA of $73.36 million far surpassed the expected $43.27 million. The company issued third-quarter revenue guidance of $647.5 million at the midpoint, above the $618.2 million analyst forecast, citing sustained momentum in travel nurse and allied staffing volumes, which grew at their highest rate in four years. CEO Caroline Grace attributed the outperformance to broad-based demand, technology-driven improvements in fill rates, and targeted acquisitions, while CFO Brian Scott noted the company is well positioned to capitalize on further demand acceleration and industry consolidation.
StockStory·16dRead more ▾
AMN

AMN Healthcare Stock May Be 13% Below Fair Value After Q2 Earnings Beat

AMN Healthcare Services may be trading about 13% below its intrinsic value according to a Discounted Cash Flow analysis, even after a 138.1% year-to-date rally. The DCF model, based on trailing free cash flow of roughly $399.4 million, estimates fair value at around $41.32 per share, implying a 12.9% discount to the current price. The recent second-quarter 2026 results, which included revenue of $673.2 million and net income of $21.2 million, support the cash-flow-based valuation. However, a Fair Ratio model that adjusts for growth, margins, and risk suggests a benchmark P/E of about 2.1 times, making the stock appear overvalued on earnings at its current multiple of 13.3 times. Overall, AMN Healthcare screens as undervalued on three of six valuation measures, leaving a mixed picture.
Simply Wall St·17dRead more ▾
AMN

AMN Healthcare Stock Gains 126.9% Year to Date on MSP Momentum and AI Investments

AMN Healthcare Services has surged 126.9% year to date, driven by strength in its Managed Services Program, rising labor disruption demand, and investments in AI-driven platforms. The company added a new Locum MSP client and renewed its largest Locums contract, while its AI recruiter deployed more than 10,000 clinicians in the latest quarter. Excluding labor disruption assignments, Nurse and Allied Solutions returned to year-over-year traveler volume growth for the first time since 2022. However, physician staffing demand remains soft, and the company derives approximately 22% of consolidated revenues from Kaiser Foundation Hospitals, posing concentration risk. The Zacks Consensus Estimate for 2026 earnings per share has risen 40% over the past 60 days to $2.70.
Zacks Investment Research·50dRead more ▾
AMN

McKesson touted as top healthcare pick while AMN and Novavax flagged as sells

StockStory identified McKesson as a healthcare stock with impressive fundamentals, citing 14.3% annual revenue growth over two years, a dominant market position with $403.4 billion in revenue, and 17.9% annual EPS growth boosted by share buybacks. In contrast, it recommended selling AMN Healthcare Services due to declining travelers on assignment, falling EPS over five years, and diminishing returns on capital, and avoiding Novavax because of 22.6% annual sales declines over two years, a projected 50.7% sales drop, and cash-burning tendencies.
StockStory·56dRead more ▾
Energy Transition & Power Demand

StockStory Highlights Nextpower and TD SYNNEX as Top Picks, Advises Selling AMN Healthcare

StockStory recommends buying Nextpower and TD SYNNEX while advising investors to sell AMN Healthcare Services. Nextpower, a solar tracker provider, posted 19.3% annual revenue growth over two years and expanded its free cash flow margin by 25.3 percentage points over five years. TD SYNNEX, a global technology distributor, achieved 25.7% annual revenue growth over five years on a massive $69.77 billion revenue base, with earnings per share boosted by share buybacks. AMN Healthcare Services faces declining travelers on assignment, a 7.1% annual drop in earnings per share over five years, and waning returns on capital, with its stock trading at 37.7 times forward earnings.
StockStory·61dRead more ▾
AMN

AMN Healthcare's AI Talent Partnership and C-Suite Hires Could Shift Bull Case

AMN Healthcare appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, and expanded its AI-enabled WorkWise platform through a partnership with Brightfield. The Brightfield workforce intelligence partnership aims to integrate data-rich, AI-supported talent solutions with a focused commercial engine and people strategy, potentially improving execution across acute and nonacute care settings. While the partnership strengthens the near-term catalyst of better workforce analytics, it does not resolve key risks such as pricing pressure, impairment overhang, and margin strain from wage inflation and higher liability costs. AMN Healthcare's narrative projects $2.3 billion revenue and $140.1 million earnings by 2029, with a fair value estimate of $28.14, representing a 13% downside to its current price. Some bearish analysts assume roughly flat revenue near $2.8 billion and no return to profitability before 2029.
Simply Wall St·62dRead more ▾
AMN3

AMN Healthcare and Brightfield launch first-of-its-kind healthcare workforce intelligence partnership

AMN Healthcare and Brightfield have launched a first-of-its-kind strategic partnership to expand workforce intelligence and market transparency for healthcare organizations. The collaboration integrates Brightfield's Talent Data Exchange, which provides third-party market data and validation across clinical and non-clinical roles, with AMN's proprietary healthcare workforce insights powered by clinical labor data, analytics, and real-time intelligence from its technology platforms and client network. The combined offering aims to deliver a more complete view of workforce costs, rate competitiveness, and market dynamics, helping health systems benchmark labor rates, strengthen transparency, and move from reactive staffing to proactive, data-backed workforce planning. The partnership is part of AMN's broader WorkWise ecosystem strategy and leverages AI-driven analytics from both companies to support smarter, more confident labor decisions aligned with operational, financial, and clinical goals.
PR Newswire·63dRead more ▾